Ondo InsurTech PLC Director/PDMR Shareholding

RNS Number : 8470Q

Ondo InsurTech PLC

20 December 2024

 

20 December 2024

 

Ondo InsurTech plc

("Ondo" or the "Company")

 

Grant of Options

 

Ondo InsurTech plc (LSE: ONDO), a leading company in claims prevention technology for home insurers, the Company's Remuneration Committee has approved the grant options over 2,045,372 ordinary shares of 5p each in the Company ("Ordinary Shares") pursuant to the Company's Enterprise Management Incentive Plan (the "EMI Options") and options over a further 1,854,628 Ordinary Shares as Unapproved Share Options ("Unapproved Options").

 

The EMI Options and the Unapproved Options (together the "Options") are exercisable at a price of 36.5p, being the average closing share price over the 10 business days to 19 December 2024 and will vest across the 48 months from the date of grant.  Once vested the Options may be exercised at any time before the fifth anniversary of the date of the award.

 

The Options comprise:

 

1.    The award of 855,372 EMI Options and 1,604,628 Unapproved Options to the following directors of the Company:

 

Name	Position	Number of Ordinary Shares over which Options granted	Total number of Ordinary Shares over which Options held following grant	Total number of Ordinary Shares held	Percentage of Current Issued Share Capital held
Craig Foster	Chief Executive Officer	1,600,000	3,919,999	1,990,986	1.7%
Kevin Withington	Chief Financial Officer	600,000	1,289,071	294,480	0.3%
Mark Wood	Chairman	260,000	260,000	2,155,152	1.9%

 

 

2.    EMI Options over 1,190,000 Ordinary Shares granted to other employees of the Company on the same terms as those awarded to the Directors.

 

3.    Unapproved Options of 250,000 Ordinary Shares granted to certain other employees that do not qualify under the EMI plan, also on the same terms as the Directors.

 

Following the grant of Options, the total number of Options outstanding over unissued Ordinary Shares is 10,441,618 representing approximately 8.62% of the Company's issued share capital.

 

Enquiries

 

For further information, please visit www.ondoplc.com or contact the following:  

 

Ondo InsurTech Plc	Craig Foster, CEO Kevin Withington, CFO	[phone]
Dowgate Capital Limited (Broker & Financial Advisor)	Russell Cook Nicholas Chambers Charlie Hall	[phone]
Cassiopeia Services Limited (PR & Investor Relations)	Stefania Barbaglio	[phone]

 

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulations.

 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Craig Foster
2	Reason for the notification
a)	Position/status	Chief Executive Officer and PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Ondo InsurTech Plc
b)	LEI	2138005Y5QBJQMOOI719
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Ordinary shares of 5 pence each   ISIN: GB00BNVVGD77
b)	Nature of the transaction	Grant of options under EMI plan share and further non-approved share options
c)	Price(s) and volume(s)	Exercise price: 36.5p   EMI Options Unapproved Options 136,986 1,463,014
d)	Aggregated information	n/a
e)	Date of the transaction	20 December 2024
f)	Place of the transaction	Outside of a trading venue

 

 

 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Kevin Withington
2	Reason for the notification
a)	Position/status	Chief Financial Officer and PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Ondo InsurTech Plc
b)	LEI	2138005Y5QBJQMOOI719
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Ordinary shares of 5 pence each   ISIN: GB00BNVVGD77
b)	Nature of the transaction	Grant of options under EMI plan share and further non-approved share options
c)	Price(s) and volume(s)	Exercise price: 36.5p   EMI Options Unapproved Options 458,386 141,614
d)	Aggregated information	n/a
e)	Date of the transaction	20 December 2024
f)	Place of the transaction	Outside of a trading venue

 

 

 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mark Wood
2	Reason for the notification
a)	Position/status	Chairman and PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Ondo InsurTech Plc
b)	LEI	2138005Y5QBJQMOOI719
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Ordinary shares of 5 pence each   ISIN: GB00BNVVGD77
b)	Nature of the transaction	Grant of options under EMI plan share
c)	Price(s) and volume(s)	Exercise price: 36.5p   260,000
d)	Aggregated information	n/a
e)	Date of the transaction	20 December 2024
f)	Place of the transaction	Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHFFFFVFILALIS